Clinical Trials Logo

Clinical Trial Summary

Based on the basic data of all patients foreseen for a local hyperthermia in the participating centers the failure rate (of the Celsius TCS Hyperthermia System) and the complication rate (injury to the patients) will be recorded.


Clinical Trial Description

During this PMCF Trial from each participating center the internal data of all Celsius TCS Hyperthermia devices are collected. The participating centers are obligated to report any device-related failure and Adverse Event (injury to the patient). The center reports together with the device-internal data allows to calculate the failure and the complication rates. It will be analyzed regarding the kind of tumor and the concomitant treatment (radiotherapy and/or chemotherapy). The outcome groups (with/without failure or complication) will be analyzed regarding demographic and treatment parameters. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02896049
Study type Observational [Patient Registry]
Source Celsius42 GmbH
Contact
Status Withdrawn
Phase
Start date November 2016
Completion date November 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04078295 - A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor Phase 1/Phase 2
Active, not recruiting NCT03833700 - A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) Phase 1
Recruiting NCT04407676 - Improving Informed Consent for Early Phase Anti-Cancer Trials N/A
Recruiting NCT04420884 - A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03364049 - Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002) Phase 1
Completed NCT01543282 - Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles N/A